Related Experiment Video
Updated: Sep 18, 2025

Author Spotlight: Reprogramming Cancer Cells to iPSCs to Study Disease Progression and Treatment Targets
Published on: February 2, 2024
Oncogenic viruses rewire the epigenome in human cancer
Jhommara Bautista1,2,3, Andrés Lopez-Cortes1
1Cancer Research Group (CRG), Faculty of Medicine, Universidad de Las Américas, Quito, Ecuador.
Abstract:
Viruses contribute to approximately 15-20% of global cancer cases, yet the full spectrum of their oncogenic mechanisms continues to be uncovered. Beyond the classical roles of genome integration, chronic inflammation, and immune evasion, mounting evidence reveals that oncogenic viruses-including the human papillomavirus (HPV), Epstein-Barr virus (EBV), hepatitis B virus (HBV), hepatitis C virus (HCV), and Human T-cell leukemia virus type 1 (HTLV-1)-profoundly reshape the host epigenome to establish persistent infection and promote tumorigenesis. These viruses orchestrate widespread and durable changes in DNA methylation, histone modification, chromatin accessibility, and non-coding RNA expression, silencing tumor suppressors, deregulating oncogenic pathways, and inducing stemness-like phenotypes. In this review, we provide a comprehensive synthesis of how distinct oncogenic viruses modulate the epigenetic landscape across tissue contexts, with a focus on cervical, hepatic, and lymphoepithelial cancers. We also explore how these virus-induced epigenetic "scars" may persist after viral clearance and highlight recent advances in therapeutic targeting. Emerging therapeutic strategies that integrate oncolytic virotherapy, epigenetic drugs, and immune modulation through combinational therapy offer synergistic mechanisms to overcome immune resistance and epigenetic silencing in virus-induced cancers. These integrated approaches hold transformative potential for more durable and targeted treatment outcomes.
Insights
Oncogenic viruses reshape the host epigenome, causing DNA methylation and chromatin changes that promote cancer. New therapies combine virotherapy, epigenetic drugs, and immune modulation for better cancer treatment outcomes.
Area of Science:
- Virology
- Cancer Biology
- Epigenetics
Background:
- Viruses cause 15-20% of global cancers, with oncogenic mechanisms still under investigation.
- Beyond traditional roles, oncogenic viruses profoundly alter host epigenomes to drive persistent infections and tumorigenesis.
- Key viruses include HPV, EBV, HBV, HCV, and HTLV-1.
Purpose of the Study:
- To synthesize how oncogenic viruses modulate the epigenetic landscape.
- To focus on epigenetic changes in cervical, hepatic, and lymphoepithelial cancers.
- To explore persistent epigenetic alterations and therapeutic targeting.
Main Methods:
- Review of current literature on virus-induced epigenetic modifications.
- Analysis of DNA methylation, histone modification, chromatin accessibility, and non-coding RNA changes.
- Synthesis of therapeutic strategies including oncolytic virotherapy, epigenetic drugs, and immunotherapy.
Main Results:
- Oncogenic viruses induce widespread, durable epigenetic changes (DNA methylation, histone modification, chromatin accessibility, non-coding RNAs).
- These changes silence tumor suppressors, deregulate oncogenes, and promote stemness-like phenotypes.
- Virus-induced epigenetic changes can persist even after viral clearance.
Conclusions:
- Oncogenic viruses utilize epigenetic reprogramming as a key mechanism for tumorigenesis.
- Epigenetic 'scars' left by viruses present therapeutic opportunities.
- Combination therapies integrating virotherapy, epigenetic drugs, and immune modulation show promise for treating virus-induced cancers.
More Related Videos
Related Concept Videos
Mechanisms of Retrovirus-induced Cancers
Induced Pluripotent Stem Cells
Somatic...
Epigenetic Regulation
X-chromosome...
Rous Sarcoma Virus (RSV) and Cancer
RSV is a retrovirus that contains two copies of a plus-strand RNA genome. Its genome consists of four main open...
Cancers Originate from Somatic Mutations in a Single Cell
Cancer-Critical Genes I: Proto-oncogenes
When the function of certain critical genes, especially those involved in cell cycle regulation and cell growth signaling cascades, gets disrupted, it upsets the cell cycle progression. Such cells with unchecked cell cycles start proliferating uncontrollably and eventually develop into tumors.
Such genes that act...

